Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. Read more about Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
RESPONSE: Re: Mammographic Breast Density and Family History of Breast Cancer. Read more about RESPONSE: Re: Mammographic Breast Density and Family History of Breast Cancer.
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. Read more about Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. Read more about Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. Read more about Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Read more about Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. Read more about Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
National practice patterns and time trends in androgen ablation for localized prostate cancer. Read more about National practice patterns and time trends in androgen ablation for localized prostate cancer.
Mammographic breast density and family history of breast cancer. Read more about Mammographic breast density and family history of breast cancer.
Short-interval follow-up mammography: are we doing the right thing? Read more about Short-interval follow-up mammography: are we doing the right thing?
